Related Experiment Videos
Hypericum perforatum, a source of neuroactive lead structures
1Dipartimento di Chimica Organica e Industriale, Università degli Studi di Milano, via Venezian 21, 20133 Milano, Italy. luisella.verotta@unimi.it
Current Topics in Medicinal Chemistry
|February 7, 2003
Summary
St. John's wort (Hypericum) effectively treats mild-to-moderate depression with a good safety profile. Research suggests hyperforin, not just hypericin, is key to its antidepressant effects by influencing neurotransmitters.
Area of Science:
- Phytochemistry
- Neuroscience
- Pharmacology
Background:
- St. John's wort (Hypericum) has a long history of medicinal use, but its mechanisms of action are not fully understood.
- Initial theories attributed antidepressant activity to hypericin, but current research points to other constituents or combinations.
Purpose of the Study:
- To review the current understanding of St. John's wort's antidepressant activity and mechanisms.
- To evaluate the clinical evidence supporting its use for depression.
Main Methods:
- Review of clinical studies and research on Hypericum constituents.
- Analysis of proposed mechanisms involving neurotransmitter systems.
Main Results:
- Evidence suggests St. John's wort is beneficial for mild-to-moderate depression.
- It exhibits a favorable side effect profile compared to other antidepressants.
- Hyperforin is identified as a significant active constituent responsible for antidepressant effects.
Conclusions:
- St. John's wort demonstrates efficacy in treating mild-to-moderate depression.
- Its unique action on multiple neurotransmitter systems contributes to its therapeutic benefits.
- Hyperforin is a key component driving the antidepressant activity of Hypericum.